Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000474963 | SCV000557277 | likely benign | Hereditary spastic paraplegia 11 | 2024-12-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001721516 | SCV000719628 | likely benign | not provided | 2022-06-30 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Ambry Genetics | RCV002446868 | SCV002753005 | likely benign | Inborn genetic diseases | 2020-02-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV002467828 | SCV002764004 | likely benign | Amyotrophic lateral sclerosis type 5 | criteria provided, single submitter | clinical testing | ||
Genome- |
RCV002467829 | SCV002764005 | likely benign | Charcot-Marie-Tooth disease axonal type 2X | criteria provided, single submitter | clinical testing | ||
Genome- |
RCV000474963 | SCV002764007 | likely benign | Hereditary spastic paraplegia 11 | criteria provided, single submitter | clinical testing |